Stay updated on Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    New data points were added to the study record, including several key dates (2026-01-02, 2023-08-04, 2027-09-01, 2025-12-30) and a Last Update Posted (Estimated) label. Older sponsor details and past update entries (e.g., Nancy Chan, MD, Big Ten Cancer Research Consortium) were removed.
    Difference
    0.8%
    Check dated 2026-01-06T02:04:22.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    - Added a new Locations section listing Michigan, Nebraska, New Jersey, New York, and Wisconsin. Removed the separate Michigan, Nebraska, New Jersey, New York, and Wisconsin location blocks.
    Difference
    0.7%
    Check dated 2025-12-22T20:39:48.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; this appears to be a minor backend or formatting change with no edits to study details, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-08T18:46:47.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1 on the page.
    Difference
    0.1%
    Check dated 2025-11-24T14:48:22.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The funding status warning banner was removed from the page, removing the notice about potential information delays due to government funding. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:55:58.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Study Details page appears unchanged; no additions or deletions detected.
    Difference
    0.5%
    Check dated 2025-11-03T01:19:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Fulvestrant in HR+ HER2- Breast Cancer Clinical Trial page.